Clinical Trial Update: Safety and Efficacy of Topical Sodium Metabisulfite for the Treatment of Calcinosis in Patients With Systemic Sclerosis [Phase 1, Phase 2]

View source ↗

Summary

A clinical trial investigating topical sodium metabisulfite for calcinosis in systemic sclerosis is listed as Phase 1/Phase 2 with unknown status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Calcinosis
• Systemic Sclerosis

Drugs mentioned

• Sodium metabisulfite (topical) (sodium metabisulfite)

Snippet

Sponsor: Pontificia Universidad Catolica de Chile | Conditions: Systemic Sclerosis, Calcinosis | Phase 1, Phase 2 | Status: UNKNOWN